A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection

Clinical trial NCT02765802 · COMPLETED

Trial details

NCT number: NCT02765802
Sponsor: Eiger BioPharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis D, Chronic

Start date: 2016-10-19
Primary completion: 2018-07-20
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.